US 12103960
VEGF traps and mini-traps and methods for treating ocular disorders and cancer
granted A61KA61K38/00A61K47/65
Quick answer
US patent 12103960 (VEGF traps and mini-traps and methods for treating ocular disorders and cancer) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K47/65, A61P, A61P27/02